Interline Brands (IBI) Misses Q2 EPS by 3c; Revs Light

Interline Brands (NYSE: IBI) reported Q2 EPS of $0.32, $0.03 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $334.8 million versus the consensus estimate of $336.72 million.

For earnings history and earnings-related data on Interline Brands (IBI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c